Brian Schwartz

Insider Reports History

Entity
Individual
Location
C/O Arqule, Inc., 1 Wall Street, 6 Th Floor, Burlington, MA
Signature
/s/ Brian Schwartz
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Schwartz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclacel Pharmaceuticals, Inc. Interim Chief Medical Officer, Director Common Stock 15.2K $50.4K $3.32 Jan 29, 2024 Direct
INFINITY PHARMACEUTICALS, INC. Director Common Stock 30.9K $2.16K $0.07 Jun 16, 2022 Direct
INFINITY PHARMACEUTICALS, INC. Director Stock Option(right to buy) 45K Jun 16, 2022 Direct
Cyclacel Pharmaceuticals, Inc. Interim Chief Medical Officer, Director Stock Option (right to buy) 12.5K Jan 29, 2024 Direct

Insider Reports Filed by Brian Schwartz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCC Cyclacel Pharmaceuticals, Inc. Jan 29, 2024 2 $0 4 Jan 31, 2024 Interim Chief Medical Officer, Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 30, 2023 2 $0 4 Jul 3, 2023 Director
INFI INFINITY PHARMACEUTICALS, INC. Jun 16, 2022 2 $21K 4 Jun 16, 2022 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 14, 2022 2 $0 4 Jun 16, 2022 Director
INFI INFINITY PHARMACEUTICALS, INC. Sep 7, 2021 1 $0 4 Sep 10, 2021 Director
INFI INFINITY PHARMACEUTICALS, INC. Sep 7, 2021 0 $0 3 Sep 10, 2021 Director
CYCC Cyclacel Pharmaceuticals, Inc. Jun 15, 2021 4 $0 4 Jun 17, 2021 Director